{
  "id": "5e3aab25b5b409ea5300001a",
  "type": "summary",
  "question": "What is the purpose of the Barricaid annular closure device?",
  "ideal_answer": "Barricaid annular closure device can improve outcome after lumbar discectomy by reducing the risk of recurrent disc herniation of the same level.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/27169045",
    "http://www.ncbi.nlm.nih.gov/pubmed/29075906",
    "http://www.ncbi.nlm.nih.gov/pubmed/23429676",
    "http://www.ncbi.nlm.nih.gov/pubmed/27236580",
    "http://www.ncbi.nlm.nih.gov/pubmed/27879508",
    "http://www.ncbi.nlm.nih.gov/pubmed/30115053",
    "http://www.ncbi.nlm.nih.gov/pubmed/31464935",
    "http://www.ncbi.nlm.nih.gov/pubmed/23473658"
  ],
  "snippets": [
    {
      "text": "We report the unusual case of a young patient with reoperation after annuloplasty using the Barricaid\u00ae (Intrinsic Therapeutics, Woburn, MA, USA) closure device. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29075906",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Annular closure devices such as the Barricaid system aim to improve outcome after lumbar discectomy by reducing the risk of recurrent disc herniation of the same level. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29075906",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Several prosthesis and techniques to reduce re-herniation have been proposed including implantation of an annular closure device (ACD) - Barricaid\u2122 and an annular tissue repair system (AR) - Anulex-Xclose\u2122. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30115053",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "CONCLUSION: Early results showed the use of Barricaid and Anulex devices are beneficial for short term outcomes demonstrating reduction in symptomatic disc reherniation with low post-operative complication rates.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30115053",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "PRESENTATION OF CASE: We present a clinical case of a patient with transpedicular and interbody fixation reoperation after annuloplasty with Barricaid closure device. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27236580",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "ONCLUSIONS: Implantation of a novel annular repair device was associated with greater maintenance of disk height and improved 1-year leg pain, back pain, and low-back disability. Recurrent disk herniation did not occur in any patient after annular repair. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27879508",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "his study investigated whether implantation with the Barricaid annular closure device (ACD) during discectomy reduced the rate of facet degeneration",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23473658",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Patients implanted with Barricaid had significantly reduced rates and grades of facet degeneration than patients without Barricaid. Reinforcing the annulus fibrosus with Barricaid during lumbar discectomy may slow the progression of facet joint degeneration.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23473658",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Use of Annular Closure Device (Barricaid\u00ae) for Preventing Lumbar Disc Reherniation: One-Year Results of Three Cases",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27169045",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "The Barricaid annular closure device provides durable occlusion of the annular defect and has been shown to significantly lower the risk of symptomatic reherniation in a large European randomized trial.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31464935",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Multicenter study of lumbar discectomy with Barricaid annular closure device for prevention of lumbar disc reherniation in US patients: A historically controlled post-market study protocol.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31464935",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "DESIGN AND METHODS\n\nThis is a historically controlled post-market multicenter study to determine the safety and efficacy of the Barricaid device when used in addition to primary lumbar discectomy in a US population.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31464935",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "PRESENTATION OF CASE\n\nWe present a clinical case of a patient with transpedicular and interbody fixation reoperation after annuloplasty with Barricaid closure device.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27236580",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The aim of this article is to demonstrate the opportunities of surgical treatment of patients with lumbar disc herniation involving annuloplasty using the Barricaid closure device as the final stage and the ways to resolve possible complications requiring reoperation.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27236580",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The Barricaid seems to prevent nucleus from reherniating.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23429676",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Use of Annular Closure Device (Barricaid\u00ae) for Preventing Lumbar Disc Reherniation: One-Year Results of Three Cases.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27169045",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Effect of an Annular Closure Device (Barricaid) on Same-Level Recurrent Disk Herniation and Disk Height Loss After Primary Lumbar Discectomy: Two-year Results of a Multicenter Prospective Cohort Study.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27879508",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Annular closure devices such as the Barricaid system aim to improve outcome after lumbar discectomy by reducing the risk of recurrent disc herniation of the same level.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29075906",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The Barricaid annular closure device provides durable occlusion of the annular defect and has been shown to significantly lower the risk of symptomatic reherniation in a large European randomized trial.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31464935",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Annular closure devices such as the Barricaid system aim to improve outcome after lumbar discectomy by reducing the risk of recurrent disc herniation of the same level",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29075906",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Several prosthesis and techniques to reduce re-herniation have been proposed including implantation of an annular closure device ( ACD ) - Barricaid\u2122 and an annular tissue repair system ( AR ) - Anulex-Xclose",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30115053",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Multicenter study of lumbar discectomy with Barricaid annular closure device for prevention of lumbar disc reherniation in US patients: A historically controlled post-market study protocol",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31464935",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Effect of an Annular Closure Device ( Barricaid ) on Same-Level Recurrent Disk Herniation and Disk Height Loss After Primary Lumbar Discectomy: Two-year Results of a Multicenter Prospective Cohort Study",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27879508",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "The Barricaid annular closure device provides durable occlusion of the annular defect and has been shown to significantly lower the risk of symptomatic reherniation in a large European randomized trial",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31464935",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Use of Annular Closure Device ( Barricaid\u00ae ) for Preventing Lumbar Disc Reherniation: One-Year Results of Three Cases",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27169045",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "The Barricaid annular closure device provides durable occlusion of the annular defect and has been shown to significantly lower the risk of symptomatic reherniation in a large European randomized trial.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31464935",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "DESIGN AND METHODS\nThis is a historically controlled post-market multicenter study to determine the safety and efficacy of the Barricaid device when used in addition to primary lumbar discectomy in a US population.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31464935",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "A total of 75 patients with large annular defects will receive the Barricaid device following lumbar discectomy at up to 25 sites in the US and will return for clinical and imaging follow-up at 4 weeks, 3 months, and 1 year.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31464935",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "This study investigated whether implantation with the Barricaid annular closure device (ACD) during discectomy reduced the rate of facet degeneration.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23473658",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "The Barricaid annular closure device provides durable occlusion of the annular defect and has been shown to significantly lower the risk of symptomatic reherniation in a large European randomized trial.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31464935",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Several prosthesis and techniques to reduce re-herniation have been proposed including implantation of an annular closure device (ACD) - Barricaid\u2122 and an annular tissue repair system (AR) - Anulex-Xclose\u2122.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30115053",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "A total of 75 patients with large annular defects will receive the Barricaid device following lumbar discectomy at up to 25 sites in the US and will return for clinical and imaging follow-up at 4 weeks, 3 months, and 1 year.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31464935",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": []
}